NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?

Insider buying vs selling

Have Adial Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ADIL insiders and whales buy or sell their stock.

ADIL Shareholders

What type of owners hold Adial Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cary J. Claiborne19.24%1,520,000$480.32kInsider
William B. Stilley Iii17.64%1,393,920$440.48kInsider
Bankole A. Johnson11.05%872,720$275.78kInsider
James W. Newman Jr.5.55%438,742$138.64kInsider
Joseph Truluck3.36%265,139$83.78kInsider
Robertson H. Gilliland1.38%109,424$34.58kInsider
Geode Capital Management LLC0.87%68,850$21.76kInstitution
Manchester Capital Management LLC0.61%48,097$15.20kInstitution
Ubs Group Ag0.60%47,745$15.09kInstitution
Blackrock Inc0.35%27,770$8.78kInstitution

1 of 3

ADIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADIL3.02%58.45%
JAGX0.05%99.95%
ADTX1.13%98.87%Net Selling
ONCO3.96%96.04%
WINT0.05%99.95%Net Buying

Adial Pharmaceuticals Stock Ownership FAQ

Who owns Adial Pharmaceuticals?

Adial Pharmaceuticals (NASDAQ: ADIL) is owned by 3.02% institutional shareholders, 58.45% Adial Pharmaceuticals insiders, and 38.53% retail investors. Cary J. Claiborne is the largest individual Adial Pharmaceuticals shareholder, owning 1.52M shares representing 19.24% of the company. Cary J. Claiborne's Adial Pharmaceuticals shares are currently valued at $501.60k.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.